Login / Signup

Management of stage II seminoma: a contemporary UK perspective.

Constantine AlifrangisDavid L NicolJonathan ShamashPrabhakar Rajannull null
Published in: Scottish medical journal (2022)
A wider recognition of UK treatment heterogeneity and consideration of therapy de-escalation strategies at supra-regional sMDTs will increase stage IIA/B seminoma treatment options as part of clinical trials with oncological and quality of life endpoints.
Keyphrases
  • clinical trial
  • cross sectional
  • germ cell
  • open label
  • single cell
  • rectal cancer
  • randomized controlled trial
  • phase ii
  • robot assisted
  • minimally invasive
  • double blind